4basebio annual gross margin
2022
2023
2024
2025
4basebio Gross Margin Growth & History (4BB)
4basebio's gross margin was 57.53% for fiscal 2025.
View full 4basebio company overview4basebio annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 57.53% | −9.99 pp |
| 2024 | 2024-12-31 | 67.52% | +0.33 pp |
| 2023 | 2023-12-31 | 67.19% | −21.99 pp |
| 2022 | 2022-12-31 | 89.18% | — |
4basebio gross margin trends
Between the periods ended 2022-12-31 and 2025-12-31, 4basebio's gross margin decreased from 89.18% to 57.53%, a change of −31.65 percentage points.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as reported gross profit divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review 4basebio source filings ↗Community posts
4basebio expands synthetic-DNA manufacturing for personalised mRNA medicines
4basebio announced an expansion of its DNA offering on 7 September 2026. Manufacturing changes The company has added suite capacity and enhanced process controls and quality systems across its Cambridge high-quality and current-GMP operatio ...